Tandem Diabetes Care Raises $120 Million In Upsized IPO

Published: Nov 14, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Tandem Diabetes Care prices its 8-million-share initial public offering at $15 per share. Tandem Diabetes Care is set to begin trading on the NASDAQ stock exchange today after pricing its initial public offering of 8 million shares at $15 each, the upper end of its initial range. The amount the company actually raises could be higher than the $120 million pricing due to a 1.2 million-share over-allotment for the offering's underwriters, which if exercised would push the raise even higher. Shares are expected to begin trading today under the TNDM symbol.

Help employers find you! Check out all the jobs and post your resume.

Back to news